Gene-based medication is rapidly gaining popularity in the advancement of medicine. Through this approach in therapeutics, unmet needs in science are given solutions that would in turn provide a better quality of life for those suffering with various diseases.
Headquartered in Gaithersburg, Maryland, GenVec, Inc. is one of the pharmaceutical companies that continue to realize gene-based medicine through its technological platform. The business has a pipeline of therapeutics and vaccines that are being developed through its adenovector technology platform. As of, the lead products of the company are therapeutics for balance disorders and hearing loss. These medications are in various phases of clinical trials. The company continues to pioneer several cutting edge therapeutics based on this platform.
The company undertakes several studies using its own resources or through its partnership with other companies. Novartis is one of the leading partners of the company. GenVec, Inc. continues to publicly trade its common shares on the NASDAQ using the symbol GNVC.
No comments:
Post a Comment